Thirumalai Chemicals Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Thirumalai Chemicals Ltd trades at ₹165, in a downtrend and 34 weeks into that stage. That is −21.0% against its own 200-day average. It sits at 2% of a 52-week range of ₹162 to ₹325. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (10 weeks and counting).

Today the stock is in a downtrend — week 34 of stage 4, confirmed. At ₹165 it trades −21.0% versus its 200-day average and sits at 2% of its 52-week range (₹162–₹325).

Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +852% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (10 weeks and counting; last ahead the week of 2026-06-09) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 97th percentile of its own range.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Thirumalai Chemicals Ltd trades at 50.0× P/E, at the pricey end of its own range (97th percentile). Its long-run median P/E is 10.7×, measured across 7.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 50.0× is at the pricey end of its own range (97th percentile), against a long-run median of 10.7× measured over 7.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

The price move, decomposed: over 5y, of the −0.3%/yr price move, ~−24.8%/yr came from earnings growth and ~+24.5 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Thirumalai Chemicals Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 2 curves, on partial evidence.

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.

4-Factor Sector Score

24.5/100 — rank 27 of 27 in Speciality Chemicals · 59% evidence confidence

Thirumalai Chemicals Ltd scores 24.5 out of 100 against the 27 companies it is compared with in Speciality Chemicals, ranking 27. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 8.6 + 1.4 + 10 + 4.5 = 24.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Thirumalai Chemicals Ltd reported ₹424 Cr of revenue in the Mar 26 quarter, −18.9% year on year. Over 10 years it has compounded at 6.3% a year. The last full year, FY26, came in at ₹1,736 Cr. The last four reported quarters add to ₹1,735 Cr.

Thirumalai Chemicals Ltd reported ₹424 Cr of revenue in the Mar 26 quarter, −18.9% year on year. Over 10 years it has compounded at 6.3% a year. The last full year, FY26, came in at ₹1,736 Cr. The last four reported quarters add to ₹1,735 Cr.

FY26 revenue came in at ₹1,736 Cr (−15.3% on the year), capping 10 years at 6.3% compound. The latest quarter (Mar 26) printed ₹424 Cr, −18.9% year on year.

Pace check: the last four quarters averaged −15.0% growth against the decade's 6.3% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −15.4% over the last 4 quarters against −8.8%/yr over the last 8 — rolling over.

→ Revenue slipped — did margins hold as it scaled? Next: 1.0% this quarter (−2.0 pp YoY).

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Thirumalai Chemicals Ltd's operating margin is 1.0% in the Mar 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −2.0% to 22.0%. The current quarter sits inside that band.

Thirumalai Chemicals Ltd's operating margin is 1.0% in the Mar 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −2.0% to 22.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 1.0%, −2.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −2.0%–22.0%.

🚨 Why the margin moved: operating margin went −1.4 pp year on year while gross margin went −0.5 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

→ Margins slipped — did that reach the bottom line? Next: profit null in the latest quarter.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Thirumalai Chemicals Ltd posted a net loss of ₹28.0 Cr in the Mar 26 quarter. The full FY26 year was a loss of ₹168 Cr. That loss is 6.6% of the quarter's revenue. The same quarter a year earlier lost ₹14.0 Cr. 9 of the last 12 reported quarters were loss-making.

Thirumalai Chemicals Ltd posted a net loss of ₹28.0 Cr in the Mar 26 quarter. The full FY26 year was a loss of ₹168 Cr. That loss is 6.6% of the quarter's revenue. The same quarter a year earlier lost ₹14.0 Cr. 9 of the last 12 reported quarters were loss-making.

Mar 26 profit was ₹−28.0 Cr, null year on year. On the full year, FY26 printed ₹−168 Cr (null).

→ Profit rose — but did the cash follow? Next: 138% of the last 3 years' profit arrived as cash.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 138% of Thirumalai Chemicals Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−131 Cr of operating cash against ₹−168 Cr of profit. After ₹1,254 Cr of capital spending, ₹−1,385 Cr was left as free cash.

FY26: operating cash of ₹−131 Cr against reported profit of ₹−168 Cr, leaving free cash of ₹−1,385 Cr after ₹1,254 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 138% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 138%: the cash cycle stretched 40 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 13.7× depreciation over three years, so the next section's job is to check what that build-out is buying.

→ So follow the cash to where it goes. Next: ₹2,904 Cr of building over 3 years.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Thirumalai Chemicals Ltd's cash conversion cycle runs 14 days in FY26, up from −26 days in FY21. Capital spending ran ₹2,904 Cr over the last 3 years. At FY26 sales of ₹1,736 Cr each day of that cycle holds about ₹4.8 Cr, so roughly ₹67.0 Cr sits inside the business at any moment.

FY26: debtors at 41 days, inventory at 50 days — roughly 1.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 14 days, looser than FY21's −26.

The full loop: cash goes out to suppliers and production on day 0; stock waits 50 days to sell; customers pay about 41 days after that; and suppliers themselves are paid at 77 days — netting out to the 14-day cycle.

In money terms: at FY26 sales of ₹1,736 Cr, each day of the cycle holds about ₹4.8 Cr — so the 14-day loop keeps roughly ₹67.0 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹2,904 Cr over the last 3 fiscal years against ₹212 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹2,518 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

→ Does all this activity actually earn its cost of capital? Next: ROCE is −3% and the ROIC − WACC spread is −15.1 pp.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Thirumalai Chemicals Ltd earns a ROCE of −3% in FY26. Return on invested capital clears the cost of that capital by −15.1 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −9.7% net margin on 0.37× asset turns.

FY26 ROCE is −3%.

🚨 Why the return is what it is — the wiring (FY26): −9.7% net margin × 0.37× asset turns × 3.03× balance-sheet leverage ≈ −10.9% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: −3.1% − 12.0% = a −15.1 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 1.39.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Thirumalai Chemicals Ltd carries total debt of ₹2,175 Cr against shareholder equity of ₹1,564 Cr as of Mar 26, a debt-to-equity of 1.39. On the annual view that ratio went from 0.15 in FY22 to 1.39 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹2,175 Cr against shareholder equity of ₹1,564 Cr — a debt-to-equity of 1.39. On the annual view, debt-to-equity went from 0.15 (FY22) to 1.39 (FY26). Read the returns on this page with that leverage in mind.

→ Who owns this, and are they adding or leaving? Next: Domestic institutions added 8.8 points over 8 quarters.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Domestic institutions added 8.8 points of Thirumalai Chemicals Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 10.1% of the company. Promoters moved −4.8 points over the same window, to 37.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: +8.8 points over 8 quarters to 10.1%; Promoters: −4.8 points over 8 quarters to 37.1%; Foreign institutions: −1.0 points over 8 quarters to 1.5%.

Why the register moved: domestic institutions drove it (+8.8 points), absorbed on the other side by promoters (−4.8 points) — steady accumulation by institutions reading the same numbers this page reads.

→ One last check: does the safety math agree? Next: the balance-sheet safety line.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Thirumalai Chemicals Ltd: the Z-score reads 0.89. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

🚨 Why it matters: a Z-score of 0.89 is inside the distress zone — the balance sheet is a real risk, not a detail.

The safety line in one sentence: the Z-score reads 0.89.

Frequently asked questions